Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists;Reacciones adversas a pruebas cutáneas e inmunoterapia en la práctica de alergólogos mexicanos

Revista Alergia Mexico

Volumn 55, Issue 2, 2008, Pages 62-70

  Linnemann, Désirée Larenas ^a,d   Pérez, Noel Rodríguez ^b   Becerril, Martín ^c  

^a LIVER RESEARCH UNIT   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d Servicio de Investigación Hospital Médica Sur   (Mexico)

Author keywords

Adverse reaction; Allergist; Anaphylaxis; Desensitization; Immunotherapy; Systemic reaction

Indexed keywords

POLLEN ANTIGEN;

ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ASTHMA; CONSULTATION; DERMATOPHAGOIDES; IMMUNOTHERAPY; QUESTIONNAIRE; SKIN TEST; URTICARIA;

EID: 77953365529     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bousquet J, Khaltaev N, Cruz AA. Allergic rhinitis and its impact on asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**). Allergy 2008;63(Suppl 86):8-160.
2. O'Byrne P, Bateman ET, Bousquet J, et al. Global strategy for asthma management and prevention. www.ginasthma.org visitado por última vez el 7 de abril de 2008.
3. a ed. México: Editorial Médica Panamericana, 2007 (en prensa).
4. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-8.
5. Des Roches A, Paradis L, Knani J, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. J Allergy 1996;51:430-3.
6. The European Academy of Allergology and Clinical Immunology (EAACI) position paper. Consensus statement on the treatment of allergic rhinitis. Allergy 2000;55:116-34.
7. Bousquet J, Lockey RF, Malling HJ. WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(suppl. 44):1-42.
8. Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group: World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl.):S147-S334.
9. Passalacqua G, Durham SR in cooperation with GA2 LEN. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007;119:881-91.
10. Cox L, Li JT, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120:S25-S85.
11. Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy 1999;54:1022-41.
12. Busse W and third expert panel of the management of asthma. Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 2007;120:S94-S138.
13. Noon L. Prophylactic inoculation against hay fever. Lancet 1911;1:1572-3.
14. Freeman J. Further observations of the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet 1911;2:814-7.
15. st ed. New York: Global Medical Communications Publishers, 1994;pp:114-27.
16. Lockey RF, Nicoara Kasti GL, Theodoropoulos DS, Bukantz SC. Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(Suppl):47-55.
17. Ávila Castañón L, Lerma Ortiz L, Velázquez Armenta Y, del Río Navarro BE, Sienra Monge JJ. Adverse reactions to immunotherapy in pediatric patients. Rev Alerg Mex 2003;50(5):182-6.
18. Rodríguez NP, Ambríz MMJ, Pizarro UE. Non-fatal systemic reactions caused by immunotherapy and skin tests. Rev Alerg Mex 2002;49:69-73.
19. Rodríguez Pérez N, Ambríz Moreno MJ. Safety of immunotherapy and skin tests with allergens in children younger than five years. Rev Alerg Mex 2006;53(2):47-51.
20. Larenas Linnemann D, Guidos Fogelbach GA, Arias Cruz A. Patrones de práctica de alergólogos mexicanos en cuanto a pruebas cutáneas con alergenos en 2005-2006. Rev Alérgica Méx 2008;55:10-17.
21. Lockey RF, Benedict LM, Turkeltaub PC, et al. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987;79:660-77.
22. Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92:6-15.
23. Bernstein DI, Wanner M, Borish L, et al and the Immunotherapy Committee of the American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004;113:1196-203.
24. Larenas Linnemann D, Guidos Fogelbach GA, Arias Cruz A. Patrones de práctica de alergólogos mexicanos en cuanto a inmunoterapia con alergenos. Rev Alerg Mex 2008;55(2):53-61.
25. Amin HS, Liss GM, Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006;117:169-75.
26. Tinkelman DG, Cole WQ 3rd, Tunno J. Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 1995;95:8-14.
27. Schwindt CD, Hutcheson PS, Leu SY, Dykewicz MS. Role of intradermal skin tests in the evaluation of clinically relevant respiratory allergy assessed using patient history and nasal challenges. Ann Allergy Asthma Immunol 2005;94:627-33.
28. Oppenheimer J, Nelson HS. Skin testing: a survey of allergists. Ann Allergy Asthma Immunol 2006;96:19-23.
29. Cox LS, Linnemann DL, Nolte H, Weldon D, Finegold I, Nelson H. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 2006;117(5):1021-35.
30. Di Rienzo V, Pagani A, Parmiani S, Passalacqua G, Canonica GW. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy 1999;54:1110-3.
31. Antico A, Pegani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006;61:1236-7.
32. Eifan AO, Keles S, Bahceciler NN, Barlan IB. Anaphylaxis by multiple pollen allergen sublingual immunotherapy. Allergy 2007, e-pub.
33. Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy 2006;61:1235.
34. Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008;63:374-81.
35. Rodríguez Pérez N, Ambríz Moreno MJ, Canonica GW, Penagos M. Frequency and risk factors associated with acute systemic reactions in patients with allergic asthma and rhinitis treated with sublingual immunotherapy. Ann Allergy Asthma Immunol 2007;98(Suppl. 1):A76.
36. Rezvani M, Bernstein DI. Anaphylactic reactions during immunotherapy. Immunol Allergy Clin North Am 2007;27:295-307.